dihydroxyphenylalanine has been researched along with Facial Palsy in 3 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mendell, JR | 1 |
Engel, WK | 1 |
Chase, TN | 1 |
Matthews, WB | 1 |
Claveria, LE | 1 |
Calne, DB | 1 |
Allen, JG | 1 |
1 review available for dihydroxyphenylalanine and Facial Palsy
Article | Year |
---|---|
Advances in neurology.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens | 1972 |
2 other studies available for dihydroxyphenylalanine and Facial Palsy
Article | Year |
---|---|
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism.
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Eye Movements; Facial Paralysis; Humans; Male; Middle Aged; | 1970 |
"On-off" phenomena related to high plasma levodopa.
Topics: Aged; Cognition Disorders; Dihydroxyphenylalanine; Facial Paralysis; Female; Humans; Intestinal Abso | 1973 |